Yuh-Min Chen - Concepedia

Author

Yuh-Min Chen

Taipei Veterans General Hospital

Also Known As

Chen, Yuh-Min, Richard Houlston, Wan-Ching Liou, YUH-MIN CHEN, Yuan-Hung Wu, Yuh-Jen Chen, Yuh-Min Chen, Yuh‐Min CHEN

135

Publications

6.7K

Citations

H-Index

150

Concepts

All Affiliations

Taipei Veterans General Hospital National Yang Ming Chiao Tung University National Health Research Institutes Taichung Veterans General Hospital

About

Yuh-Min Chen is an author at Taipei Veterans General Hospital specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	7	7	1.2K
2	Engineering	6	6	140
3	Business	3	3	137
4	Arts	1	1	20
5	Language Studies	1	1	26

Yuh-Min Chen

Publications

Citations

H-Index

Page 1

	Year	Citations
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial Vincent A. Miller, Vera Hirsh, Jacques Cadranel, The Lancet Oncology OncologyPhase 2B/3Afatinib Versus PlaceboClinical TrialsLux-lung 1	2012	950
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations Paul K. Paik, Enriqueta Felip, Rémi Veillon, New England Journal of Medicine	2020	819
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Qing Lan, Chao A. Hsiung, Keitaro Matsuo, Nature Genetics Genome-wide Association StudyTobacco ControlEpidemiologyMedicineGenetics	2012	346
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial Yi‐Long Wu, Jin Soo Lee, Sumitra Thongprasert, The Lancet Oncology OncologyMedicineMetronomic TherapyDouble-blind TrialBronchial Neoplasm	2013	304
Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer Tony Mok, Yi‐Long Wu, Chong‐Jen Yu, Journal of Clinical Oncology	2009	220
The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia Chao A. Hsiung, Qing Lan, Yun‐Chul Hong, PLoS Genetics	2010	210
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types Joshua N. Sampson, William A. Wheeler, Meredith Yeager, JNCI Journal of the National Cancer Institute	2015	189
Sleep apnea and risk of pneumonia: a nationwide population-based study Vincent Yi‐Fong Su, Chia‐Jen Liu, Hsin-Kai Wang, Canadian Medical Association Journal	2014	146
Health-Related Quality-of-Life in a Randomized Phase III First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced NSCLC (IPASS) Sumitra Thongprasert, Emma Duffield, Nagahiro Saijo, Journal of Thoracic Oncology Advanced NsclcOncologyCancer ManagementClinical TrialsPharmacotherapy	2011	133
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study Yung‐Hung Luo, Lei Luo, Jason A. Wampfler, The Lancet Oncology Tobacco ControlHealth PolicyCancer ScreeningLung Cancer EligibleMedicine	2019	113

Page 1